Phase I trial of the angiogenesis inhibitor TNP-470 (AGM-1470) in patients with androgen independent prostate cancer
収録刊行物
-
- Proc. Am. Soc. Clin. Oncol.
-
Proc. Am. Soc. Clin. Oncol. 13 252-, 1994